Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBushveld Minerals Regulatory News (BMN)

Share Price Information for Bushveld Minerals (BMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.57
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (18.182%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.57
BMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

27 Dec 2023 14:30

RNS Number : 9660X
Bushveld Minerals Limited
27 December 2023

Market Abuse Regulation ("MAR") Disclosure

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

27 December 2023

Bushveld Minerals Limited

("Bushveld" or the "Company")

General Meeting Results

Bushveld Minerals Limited (AIM: BMN), the integrated primary vanadium producer, is pleased to announce that all ordinary and special resolutions put to shareholders at the General Meeting held earlier today were duly passed.

No.

Ordinary Resolution

Votes

In Favour

Against

Withheld

1

To grant the Directors the authority to issue the New Shares, the BEE Consortium Pre-emption Shares and the SPR Option Shares and the maximum number of Orion Conversion Shares that may be issuable on an Orion Conversion in accordance with Article 8.3 of the Articles ("Resolution 1" of the circular)

779,492,174

11,854,933

927,811

2

To provide the flexibility to the Directors to issue shares from time to time and grant the authority until the next annual general meeting (unless such authority is revoked or renewed prior to such time) by authorising the Directors in accordance with Article 8.3 of the Articles to issue relevant securities up to an aggregate nominal amount equal to approximately one third of the Enlarged Share Capital ("Resolution 3" of the circular).

775,167,570

16,178,973

928,375

Special Resolution

3

To grant the Directors the authority to issue the New Shares, the BEE Consortium Pre-emption Shares and the SPR Option Shares and the maximum number of Orion Conversion Shares that may be issuable on an Orion Conversion as if the pre-emption rights contained in Article 9.2 of the Articles did not apply to such issue ("Resolution 2" of the circular).

777,189,029

13,283,193

1,802,696

4

To disapply the pre-emption rights contained in Article 9.9 of the Articles in respect of the issuance of equity securities for cash pursuant to rights issues and other pre-emptive issues, and in respect of other issues of equity securities for cash up to an aggregate nominal value which equates to approximately 10 per cent of the Enlarged Share Capital ("Resolution 4" of the circular).

777,440,625

13,253,943

1,580,350

Admission, Settlement and Total Voting Rights

An application has been made to the London Stock Exchange for the 395,897,277 Fundraise Shares and 124,267,747 Orion Shares to be admitted to trading on AIM. It is expected that Admission will become effective and dealings in the Fundraise Shares and Orion Shares to be issued pursuant to the Fundraise will commence on or around 28 December 2023.

Following Admission, there will be a total of 2,311,213,138 Ordinary Shares in issue, 670,000 of which are held in treasury. Shareholders should use the figure of 2,310,543,138 as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the FCA's Disclosure and Transparency Rules.

The new Ordinary Shares to be issued pursuant to the PrimaryBid Offer will be issued free of all liens, charges and encumbrances and will, on Admission, rank pari passu in all respects with the new Ordinary Shares to be issued pursuant to the Placing, the Subscription and the Company's existing Ordinary Shares.

Furthermore, as announced on 5 December 2023, Acacia Resources Limited subscribed for 92,592,592 new ordinary shares of 1 pence each in the Company, which will be settled on or before 28 February 2024. A separate AIM application and announcement will be made regarding the admission of these shares to trading on AIM.

Craig Coltman, CEO of Bushveld Minerals Limited, commented:

"I would like to thank the shareholders for voting in favour of all the resolutions. Your support is of utmost importance as the equity raise which will provide the necessary resources for the Company to meet its financial obligations, increase production and ensure stability."

Enquiries: info@Bushveldminerals.com

Bushveld Minerals Limited

+27 (0) 11 268 6555

Craig Coltman, Chief Executive Officer

Chika Edeh, Head of Investor Relations

SP Angel Corporate Finance LLP

Nominated Adviser, Joint Broker & Joint Bookrunner

+44 (0) 20 3470 0470

Richard Morrison / Charlie Bouverat

Grant Barker / Richard Parlons

Hannam & Partners

Joint Broker & Joint Bookrunner

+44 (0) 20 7907 8500

Andrew Chubb / Matt Hasson / Jay Ashfield

Tavistock

Financial PR

+44 (0) 207 920 3150

Gareth Tredway / Tara Vivian-Neal / James Whitaker

ENDS

ABOUT BUSHVELD MINERALS LIMITED

Bushveld Minerals is a vertically integrated primary vanadium producer, it is one of only three operating primary vanadium producers. In 2022, the Company produced more than 3,800 mtV, representing approximately three per cent of the global vanadium market. With a diversified vanadium product portfolio serving the needs of the steel, energy and chemical sectors.

Detailed information on the Company and progress to date can be accessed on the website www.bushveldminerals.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ROMXDLFLXLLZFBE
Date   Source Headline
6th Jan 20217:00 amRNSTotal Voting Rights
4th Jan 202111:34 amRNSHolding(s) in Company
18th Dec 20202:33 pmRNSPartial repayment of Duferco convertible loan note
30th Nov 20207:00 amRNSBushveld satisfies conditions of US$65m funding
27th Nov 20203:06 pmRNSGeneral meeting results
24th Nov 20207:00 amRNSQ3 and 9 months 2020 Operational Update
11th Nov 20207:00 amRNSVametco Mini-Grid Update
9th Nov 20207:01 amRNSCircular and Notice of GM
9th Nov 20207:00 amRNSSuccessful Raise of US$35M Convertible Loan Note
23rd Oct 202011:33 amRNSExchange Control Approval for Orion Transaction
19th Oct 20202:05 pmRNSSecond Price Monitoring Extn
19th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20207:36 amRNSInterim Results for six months to end-June 2020
30th Sep 20207:13 amRNSFinancing with Orion and Convertible Loan Note
18th Sep 20202:37 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSVanadium Rental Partnership with Invinity
2nd Sep 20207:00 amRNSQ2 2020 and H1 2020 Operational Update
5th Aug 20203:18 pmRNSResult of AGM
3rd Aug 20207:00 amRNSInvestment in Enerox GmbH
21st Jul 202012:55 pmRNSDirector/PDMR Shareholding
30th Jun 202012:27 pmRNSPosting of accounts and notice of general meeting
23rd Jun 20208:58 amRNSFinal Results for the Year Ended 31 December 2019
14th May 202011:05 amRNSSecond Price Monitoring Extn
14th May 202011:00 amRNSPrice Monitoring Extension
11th May 20202:05 pmRNSSecond Price Monitoring Extn
11th May 20202:00 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSQ1 2020 Operational Update
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
14th Apr 202011:05 amRNSSecond Price Monitoring Extn
14th Apr 202011:00 amRNSPrice Monitoring Extension
7th Apr 202011:05 amRNSSecond Price Monitoring Extn
7th Apr 202011:00 amRNSPrice Monitoring Extension
1st Apr 20203:51 pmRNSBushveld to hold 8.71% of newly created Invinity
24th Mar 20209:12 amRNSCovid-19 Update and Operation Halt
23rd Mar 202011:05 amRNSSecond Price Monitoring Extn
23rd Mar 202011:00 amRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSDirectorate Change
12th Mar 20202:06 pmRNSSecond Price Monitoring Extn
12th Mar 20202:00 pmRNSPrice Monitoring Extension
9th Mar 20204:41 pmRNSSecond Price Monitoring Extn
9th Mar 20204:36 pmRNSPrice Monitoring Extension
9th Mar 20207:00 amRNSJoint Venture agreement with redT
30th Jan 20209:17 amRNSFull Year 2019 and Q4 2019 Operational Update
19th Dec 20193:02 pmRNSUpdate on investment in Enerox GmbH ("Enerox")
12th Nov 20194:32 pmRNSPotential investment in Enerox GmbH
7th Nov 20197:01 amRNSBushveld Minerals Q3 2019 Operational Update
7th Nov 20197:00 amRNSVanchem Acquisition Completed
1st Nov 20199:46 amRNSStrategy for partnering with VRFB companies
1st Nov 20199:45 amRNSSupport for redT - Avalon Merger

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.